Display Settings:

Format

Send to:

Choose Destination
    Pharmacol Biochem Behav. 1992 May;42(1):57-60.

    Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha.

    Source

    Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

    Abstract

    In rats trained to discriminate 0.8 mg/kg IP d-amphetamine from 1 ml/kg saline, 4 x 10(6) U/kg of recombinant human interferon-alpha (rIFN-alpha) given intramuscularly 1 h prior to tests potentiated responses elicited by 0.4 mg/kg d-amphetamine. Coadministration of the opioid receptor antagonist naloxone (1 mg/kg IP) with rIFN-alpha suppressed the potentiation of d-amphetamine by the cytokine. Opioid-dopaminergic mechanisms are proposed to explain the action of rIFN-alpha.

    PMID:
    1528947
    [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Full Text Sources

    Molecular Biology Databases

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk